1. Home
  2. STC vs BCRX Comparison

STC vs BCRX Comparison

Compare STC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STC
  • BCRX
  • Stock Information
  • Founded
  • STC 1893
  • BCRX 1986
  • Country
  • STC United States
  • BCRX United States
  • Employees
  • STC N/A
  • BCRX N/A
  • Industry
  • STC Specialty Insurers
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STC Finance
  • BCRX Health Care
  • Exchange
  • STC Nasdaq
  • BCRX Nasdaq
  • Market Cap
  • STC 2.0B
  • BCRX 1.7B
  • IPO Year
  • STC N/A
  • BCRX 1994
  • Fundamental
  • Price
  • STC $59.11
  • BCRX $10.92
  • Analyst Decision
  • STC Buy
  • BCRX Buy
  • Analyst Count
  • STC 3
  • BCRX 8
  • Target Price
  • STC $77.67
  • BCRX $16.75
  • AVG Volume (30 Days)
  • STC 166.9K
  • BCRX 6.8M
  • Earning Date
  • STC 07-23-2025
  • BCRX 05-05-2025
  • Dividend Yield
  • STC 3.31%
  • BCRX N/A
  • EPS Growth
  • STC 72.76
  • BCRX N/A
  • EPS
  • STC 2.60
  • BCRX N/A
  • Revenue
  • STC $2,547,588,000.00
  • BCRX $503,485,000.00
  • Revenue This Year
  • STC $11.89
  • BCRX $36.61
  • Revenue Next Year
  • STC $12.20
  • BCRX $13.19
  • P/E Ratio
  • STC $23.17
  • BCRX N/A
  • Revenue Growth
  • STC 11.27
  • BCRX 41.67
  • 52 Week Low
  • STC $58.61
  • BCRX $5.92
  • 52 Week High
  • STC $78.44
  • BCRX $11.11
  • Technical
  • Relative Strength Index (RSI)
  • STC 31.30
  • BCRX 66.04
  • Support Level
  • STC $59.47
  • BCRX $10.46
  • Resistance Level
  • STC $60.66
  • BCRX $11.00
  • Average True Range (ATR)
  • STC 1.46
  • BCRX 0.40
  • MACD
  • STC -0.41
  • BCRX -0.02
  • Stochastic Oscillator
  • STC 5.78
  • BCRX 84.06

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: